BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
96.20+1.05 (+1.10%)
At close: 4:00PM EST
96.20 0.00 (0.00%)
After hours: 5:45PM EST
Show:
Annual
Income statement
Currency in EUR. All numbers in thousandsBreakdown
ttm
31/12/2019
31/12/2018
31/12/2017
Total revenue
164,871
108,589
127,575
61,598
Cost of revenue
22,780
17,361
13,690
9,318
Gross profit
142,091
91,228
113,885
52,280
Operating expenses
Research development
453,444
226,466
143,040
85,496
Selling general and administrative
72,781
43,410
27,090
29,492
Total operating expenses
521,635
272,746
167,738
113,557
Operating income or loss
-379,544
-181,518
-53,853
-61,277
Interest expense
1,867
1,718
1,721
676
Total other income/expenses net
-
2,341
5,966
-26,033
Income before tax
-409,940
-179,440
-47,662
-85,905
Income tax expense
-3
-268
600
45
Income from continuing operations
-409,937
-179,172
-48,262
-85,950
Net income
-409,937
-179,056
-48,019
-85,653
Net income available to common shareholders
-409,937
-179,056
-48,019
-85,653
Basic EPS
-
-0.85
-0.21
-0.38
Diluted EPS
-
-0.85
-0.21
-0.38
Basic average shares
-
211,499
226,262
226,262
Diluted average shares
-
211,499
226,262
226,262
EBITDA
-
-143,826
-23,957
-74,700
© 2021 Verizon Media. All rights reserved.
